Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis have?
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis has 253 citations in the OpenAlex counts ScholarIQ stores.
When was Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis published?
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis has 2019 year in the ScholarIQ index.
What is the open-access status of Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis?
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis has hybrid oa status in the ScholarIQ index.
What is the DOI of Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis?
The DOI for Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis is on the source record.
What is the PMID of Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis?
The PMID for Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis is on the source record.
What is the OpenAlex record for Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis?
The OpenAlex for Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis is on the source record.